Literature DB >> 30202952

Illness among US resident student travellers after return to the USA: a GeoSentinel analysis, 2007-17.

Kristina M Angelo1, N Jean Haulman2, Anne C Terry2, Daniel T Leung3, Lin H Chen4,5, Elizabeth D Barnett6, Stefan H F Hagmann7,8, Noreen A Hynes9, Bradley A Connor10,11, Susan Anderson12, Anne McCarthy13, Marc Shaw14,15, Perry J J Van Genderen16, Davidson H Hamer17,18.   

Abstract

Background: The number of US students studying abroad more than tripled during the past 20 years. As study abroad programmes' destinations diversify, students increasingly travel to resource-limited countries, placing them at risk for infectious diseases. Data describing infections acquired by US students while travelling internationally are limited. We describe illnesses among students who returned from international travel and suggest how to prevent illness among these travellers.
Methods: GeoSentinel is a global surveillance network of travel and tropical medicine providers that monitors travel-related morbidity. This study included the records of US resident student international travellers, 17-24 years old, who returned to the USA, had a confirmed travel-related illness at one of 15 US GeoSentinel sites during 2007-17 and had a documented exposure region. Records were analysed to describe demographic and travel characteristics and diagnoses.
Results: The study included 432 students. The median age was 21 years; 69% were female. More than 70% had a pre-travel consultation with a healthcare provider. The most common exposure region was sub-Saharan Africa (112; 26%). Students were most commonly exposed in India (44; 11%), Ecuador (28; 7%), Ghana (25; 6%) and China (24; 6%). The median duration of travel abroad was 40 days (range: 1-469) and presented to a GeoSentinel site a median of 8 days (range: 0-181) after travel; 98% were outpatients. Of 581 confirmed diagnoses, the most common diagnosis category was gastrointestinal (45%). Acute diarrhoea was the most common gastrointestinal diagnosis (113 of 261; 43%). Thirty-one (7%) students had vector-borne diseases [14 (41%) malaria and 11 (32%) dengue]. Three had vaccine-preventable diseases (two typhoid; one hepatitis A); two had acute human immunodeficiency virus infection. Conclusions: Students experienced travel-related infections, despite the majority having a pre-travel consultation. US students should receive pre-travel advice, vaccinations and chemoprophylaxis to prevent gastrointestinal, vector-borne, sexually transmitted and vaccine-preventable infections.

Entities:  

Mesh:

Year:  2018        PMID: 30202952      PMCID: PMC6503850          DOI: 10.1093/jtm/tay074

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  8 in total

1.  3a edizione Giornate della ricerca scientifica e delle esperienze professionali dei giovani: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI) 25-26 marzo 2022.

Authors: 
Journal:  J Prev Med Hyg       Date:  2022-07-06

2.  Patients with Chronic Diseases Who Travel: Need for Global Access to Timely Health Care Data.

Authors:  Henrik Toft Sørensen
Journal:  Clin Epidemiol       Date:  2022-04-26       Impact factor: 5.814

Review 3.  Yellow Fever in Travelers.

Authors:  Annelies Wilder-Smith
Journal:  Curr Infect Dis Rep       Date:  2019-10-31       Impact factor: 3.725

4.  ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas.

Authors:  Annelies Wilder-Smith; Raman Preet; Elizabeth B Brickley; Ricardo Arraes de Alencar Ximenes; Demócrito de Barros Miranda-Filho; Celina Maria Turchi Martelli; Thália Velho Barreto de Araújo; Ulisses Ramos Montarroyos; Maria Elisabeth Moreira; Marília Dalva Turchi; Tom Solomon; Bart C Jacobs; Carlos Pardo Villamizar; Lyda Osorio; Ana Maria Bispo de Filipps; Johan Neyts; Suzanne Kaptein; Ralph Huits; Kevin K Ariën; Hugh J Willison; Julia M Edgar; Susan C Barnett; Rosanna Peeling; Debi Boeras; Maria G Guzman; Aravinda M de Silva; Andrew K Falconar; Claudia Romero-Vivas; Michael W Gaunt; Alessandro Sette; Daniela Weiskopf; Louis Lambrechts; Helen Dolk; Joan K Morris; Ieda M Orioli; Kathleen M O'Reilly; Laith Yakob; Joacim Rocklöv; Cristiane Soares; Maria Lúcia Brito Ferreira; Rafael Freitas de Oliveira Franca; Alexander R Precioso; James Logan; Trudie Lang; Nina Jamieson; Eduardo Massad
Journal:  Glob Health Action       Date:  2019       Impact factor: 2.640

Review 5.  What Is the Impact of Lockdowns on Dengue?

Authors:  Oliver Brady; Annelies Wilder-Smith
Journal:  Curr Infect Dis Rep       Date:  2021-01-21       Impact factor: 3.663

Review 6.  Uncovering the Burden of Dengue in Africa: Considerations on Magnitude, Misdiagnosis, and Ancestry.

Authors:  Emily Mary Gainor; Eva Harris; A Desiree LaBeaud
Journal:  Viruses       Date:  2022-01-25       Impact factor: 5.048

Review 7.  Dengue vaccine development by the year 2020: challenges and prospects.

Authors:  Annelies Wilder-Smith
Journal:  Curr Opin Virol       Date:  2020-10-18       Impact factor: 7.090

Review 8.  GeoSentinel: past, present and future†.

Authors:  Davidson H Hamer; Aisha Rizwan; David O Freedman; Phyllis Kozarsky; Michael Libman
Journal:  J Travel Med       Date:  2020-12-23       Impact factor: 8.490

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.